| NTRA |
Natera, Inc. |
23.27B |
5.86% |
|
|
|
|
|
176.27 |
4.79% |
53.42% |
33.96% |
|---|
| VCYT |
Veracyte, Inc. |
3.58B |
5.41% |
|
|
|
|
|
46.14 |
3.83% |
62.23% |
37.15% |
|---|
| QGEN |
Qiagen N.V. |
9.69B |
4.66% |
|
|
|
|
|
44.51 |
1.69% |
48.39% |
15.55% |
|---|
| TECH |
Bio-Techne Corporation |
11.56B |
4.57% |
|
|
|
|
|
72.76 |
1.29% |
40.49% |
37.41% |
|---|
| BNTX |
BioNTech SE |
28.98B |
4.45% |
|
|
|
|
|
120.88 |
-0.23% |
45.15% |
46.46% |
|---|
| A |
Agilent Technologies, Inc. |
43.23B |
4.42% |
|
|
|
|
|
151.38 |
2.92% |
26.04% |
22.01% |
|---|
| BMRN |
BioMarin Pharmaceutical Inc. |
12.17B |
4.10% |
|
|
|
|
|
63.88 |
0.66% |
33.04% |
33.43% |
|---|
| ARWR |
Arrowhead Pharmaceuticals, Inc. |
2.52B |
4.10% |
|
|
|
|
|
20.23 |
1.40% |
56.04% |
58.88% |
|---|
| ILMN |
Illumina, Inc. |
21.10B |
4.09% |
|
|
|
|
|
133.01 |
0.98% |
52.61% |
50.08% |
|---|
| SRPT |
Sarepta Therapeutics, Inc. |
10.93B |
4.09% |
|
|
|
|
|
114.45 |
-0.87% |
45.47% |
10.90% |
|---|
| BEAM |
Beam Therapeutics Inc. |
2.26B |
3.76% |
|
|
|
|
|
27.28 |
5.29% |
63.92% |
57.40% |
|---|
| CRSP |
CRISPR Therapeutics AG |
3.59B |
3.68% |
|
|
|
|
|
42.04 |
2.01% |
59.06% |
29.74% |
|---|
| ALNY |
Alnylam Pharmaceuticals, Inc. |
35.75B |
3.51% |
|
|
|
|
|
277.16 |
1.16% |
41.52% |
26.27% |
|---|
| RARE |
Ultragenyx Pharmaceutical Inc. |
4.01B |
3.39% |
|
|
|
|
|
43.40 |
2.19% |
71.90% |
43.85% |
|---|
| LEGN |
Legend Biotech Corporation |
6.83B |
3.27% |
|
|
|
|
|
37.22 |
3.10% |
65.05% |
46.71% |
|---|
| MRNA |
Moderna, Inc. |
15.79B |
3.23% |
|
|
|
|
|
41.04 |
0.79% |
77.20% |
77.25% |
|---|
| TXG |
10x Genomics, Inc. |
1.83B |
2.97% |
|
|
|
|
|
15.08 |
1.62% |
81.27% |
42.91% |
|---|
| RNA |
Avidity Biosciences, Inc. |
3.89B |
2.82% |
|
|
|
|
|
32.63 |
2.22% |
67.15% |
27.44% |
|---|
| 1548.HK |
GENSCRIPT BIOTECH CORP |
|
2.76% |
|
|
|
|
|
|
|
|
|
|---|
| MYGN |
Myriad Genetics, Inc. |
1.18B |
2.47% |
|
|
|
|
|
12.91 |
2.95% |
60.35% |
64.52% |
|---|
| NTLA |
Intellia Therapeutics, Inc. |
1.07B |
2.36% |
|
|
|
|
|
10.51 |
3.85% |
84.48% |
88.51% |
|---|
| GILD |
Gilead Sciences, Inc. |
120.83B |
2.31% |
|
|
|
|
|
96.95 |
1.42% |
25.00% |
26.16% |
|---|
| CDNA |
CareDx, Inc |
1.23B |
2.17% |
|
|
|
|
|
22.98 |
1.86% |
110.71% |
46.35% |
|---|
| RCKT |
Rocket Pharmaceuticals, Inc. |
1.14B |
2.09% |
|
|
|
|
|
10.69 |
2.69% |
217.96% |
47.26% |
|---|
| VRTX |
Vertex Pharmaceuticals Incorporated |
112.90B |
1.87% |
|
|
|
|
|
438.40 |
-0.71% |
34.43% |
45.95% |
|---|
| QURE |
uniQure N.V. |
843.78M |
1.59% |
|
|
|
|
|
15.79 |
3.61% |
62.26% |
23.50% |
|---|
| VIR |
Vir Biotechnology, Inc. |
1.42B |
1.34% |
|
|
|
|
|
10.31 |
-5.41% |
70.90% |
30.65% |
|---|
| MRVI |
Maravai LifeSciences Holdings, Inc. |
716.31M |
1.33% |
|
|
|
|
|
5.05 |
0.40% |
326.40% |
36.50% |
|---|
| PSTX |
Poseida Therapeutics, Inc. |
925.93M |
1.26% |
|
|
|
|
|
9.50 |
0.00% |
142.30% |
4.60% |
|---|
| SGMO |
Sangamo Therapeutics, Inc. |
256.64M |
0.96% |
|
|
|
|
|
1.2300 |
8.85% |
152.43% |
21.86% |
|---|
| PACB |
Pacific Biosciences of California, Inc. |
438.18M |
0.95% |
|
|
|
|
|
1.6000 |
2.56% |
120.73% |
49.40% |
|---|
| FLGT |
Fulgent Genetics, Inc. |
519.98M |
0.75% |
|
|
|
|
|
17.00 |
0.89% |
88.61% |
101.43% |
|---|
| VERV |
Verve Therapeutics, Inc. |
627.36M |
0.71% |
|
|
|
|
|
7.41 |
-3.77% |
154.23% |
27.33% |
|---|
| RGNX |
REGENXBIO Inc. |
391.41M |
0.66% |
|
|
|
|
|
7.90 |
5.05% |
652.49% |
30.23% |
|---|
| ALLO |
Allogene Therapeutics, Inc. |
402.57M |
0.59% |
|
|
|
|
|
1.9200 |
4.35% |
677.77% |
57.14% |
|---|
| SANA |
Sana Biotechnology, Inc. |
779.21M |
0.40% |
|
|
|
|
|
3.49 |
7.38% |
214.00% |
35.36% |
|---|
| TSVT |
2seventy bio, Inc. |
135.16M |
0.29% |
|
|
|
|
|
2.6200 |
5.22% |
368.39% |
37.35% |
|---|
| CRBU |
Caribou Biosciences, Inc. |
118.62M |
0.27% |
|
|
|
|
|
1.3100 |
-2.24% |
1,000.13% |
33.33% |
|---|
| EDIT |
Editas Medicine, Inc. |
113.09M |
0.20% |
|
|
|
|
|
1.3700 |
2.24% |
146.68% |
70.71% |
|---|
| LYEL |
Lyell Immunopharma, Inc. |
170.39M |
0.17% |
|
|
|
|
|
0.5832 |
0.59% |
279.25% |
37.09% |
|---|
| E |
Eni S.p.A. |
45.25B |
0.01% |
|
|
|
|
|
28.45 |
1.57% |
34.22% |
38.57% |
|---|